J Belotte

512 total citations
19 papers, 316 citations indexed

About

J Belotte is a scholar working on Oncology, Reproductive Medicine and Surgery. According to data from OpenAlex, J Belotte has authored 19 papers receiving a total of 316 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Reproductive Medicine and 5 papers in Surgery. Recurrent topics in J Belotte's work include Ovarian cancer diagnosis and treatment (7 papers), PARP inhibition in cancer therapy (5 papers) and Genomics, phytochemicals, and oxidative stress (3 papers). J Belotte is often cited by papers focused on Ovarian cancer diagnosis and treatment (7 papers), PARP inhibition in cancer therapy (5 papers) and Genomics, phytochemicals, and oxidative stress (3 papers). J Belotte collaborates with scholars based in United States, Canada and United Kingdom. J Belotte's co-authors include Michael P. Diamond, Ghassan M. Saed, Nicole M. Fletcher, Awoniyi O. Awonuga, Robert Morris, Husam M. Abu‐Soud, Richard G. Moore, Gottfried E. Konecny, Zhongliang Jiang and Aine Clements and has published in prestigious journals such as PLoS ONE, Clinical Cancer Research and Free Radical Biology and Medicine.

In The Last Decade

J Belotte

14 papers receiving 309 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J Belotte United States 10 107 86 83 78 44 19 316
Salah T. Fayed Egypt 8 120 1.1× 29 0.3× 111 1.3× 84 1.1× 84 1.9× 16 337
Doo Byung Chay South Korea 13 96 0.9× 48 0.6× 84 1.0× 79 1.0× 34 0.8× 27 311
Lyndsay Willmott United States 10 136 1.3× 42 0.5× 129 1.6× 106 1.4× 42 1.0× 36 381
Yuko Shiroyama Japan 11 103 1.0× 50 0.6× 84 1.0× 106 1.4× 20 0.5× 26 307
Shunji Kamazawa Japan 9 185 1.7× 36 0.4× 177 2.1× 132 1.7× 26 0.6× 13 371
Xiaohua Wu China 3 174 1.6× 66 0.8× 122 1.5× 53 0.7× 35 0.8× 3 407
Marsha Jones United States 9 164 1.5× 43 0.5× 60 0.7× 89 1.1× 10 0.2× 11 349
Gabriel Lindahl Sweden 9 107 1.0× 29 0.3× 304 3.7× 207 2.7× 52 1.2× 22 425
Shruthi Sriramkumar United States 8 191 1.8× 18 0.2× 103 1.2× 55 0.7× 70 1.6× 10 352
Alberto Serrano‐Olvera Mexico 8 113 1.1× 34 0.4× 141 1.7× 80 1.0× 25 0.6× 10 331

Countries citing papers authored by J Belotte

Since Specialization
Citations

This map shows the geographic impact of J Belotte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Belotte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Belotte more than expected).

Fields of papers citing papers by J Belotte

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Belotte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Belotte. The network helps show where J Belotte may publish in the future.

Co-authorship network of co-authors of J Belotte

This figure shows the co-authorship network connecting the top 25 collaborators of J Belotte. A scholar is included among the top collaborators of J Belotte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Belotte. J Belotte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
3.
Krivak, Thomas C., Gail S. Wright, Erika Hamilton, et al.. (2022). OVARIO phase II trial of combination niraparib plus bevacizumab maintenance therapy in advanced ovarian cancer following first-line platinum-based chemotherapy with bevacizumab. Gynecologic Oncology. 166(2). 219–229. 44 indexed citations
4.
5.
Krivak, Thomas C., Gail S. Wright, Erika Hamilton, et al.. (2021). Phase II OVARIO Study of niraparib + bevacizumab therapy in advanced ovarian cancer following front-line platinum-based chemotherapy with bevacizumab. Gynecologic Oncology. 162. S17–S17. 13 indexed citations
6.
Belotte, J, et al.. (2016). The Role of Angiogenesis in the Persistence of Chemoresistance in Epithelial Ovarian Cancer. Reproductive Sciences. 23(11). 1484–1492. 18 indexed citations
7.
Fletcher, Nicole M., et al.. (2016). Specific point mutations in key redox enzymes are associated with chemoresistance in epithelial ovarian cancer. Free Radical Biology and Medicine. 102. 122–132. 30 indexed citations
8.
Belotte, J, Nicole M. Fletcher, Mohammed S. Abusamaan, et al.. (2015). A Single Nucleotide Polymorphism in Catalase Is Strongly Associated with Ovarian Cancer Survival. PLoS ONE. 10(8). e0135739–e0135739. 16 indexed citations
9.
Belotte, J, et al.. (2014). Successful Laparoscopic Management of Ruptured Tubal Pregnancy with an Ipsilateral Ectopic Pelvic Kidney. Case Reports in Obstetrics and Gynecology. 2014. 1–4.
10.
Belotte, J, Nicole M. Fletcher, Robert Morris, et al.. (2014). Sox2 Gene Amplification Significantly Impacts Overall Survival in Serous Epithelial Ovarian Cancer. Reproductive Sciences. 22(1). 38–46. 30 indexed citations
11.
Awonuga, Awoniyi O., Nicole M. Fletcher, Mohammed S. Abusamaan, et al.. (2014). The in-vivo effects of superoxide dismutase on the incidence and severity of post-operative adhesion development. Fertility and Sterility. 102(3). e73–e73.
12.
Awonuga, Awoniyi O., et al.. (2014). Advances in the Pathogenesis of Adhesion Development: The Role of Oxidative Stress. Reproductive Sciences. 21(7). 823–836. 68 indexed citations
13.
Deppe, Gunter, İsmail Mert, J Belotte, & Ira Winer. (2013). Chemotherapy of vulvar cancer: a review. Wiener klinische Wochenschrift. 125(5-6). 119–128. 9 indexed citations
14.
Belotte, J, Nicole M. Fletcher, Awoniyi O. Awonuga, et al.. (2013). The Role of Oxidative Stress in the Development of Cisplatin Resistance in Epithelial Ovarian Cancer. Reproductive Sciences. 21(4). 503–508. 28 indexed citations
15.
Belotte, J, Nicole M. Fletcher, Awoniyi O. Awonuga, et al.. (2013). Abstract B49: The role of oxidative stress in the development of cisplatin resistance in epithelial ovarian cancer. Clinical Cancer Research. 19(19_Supplement). B49–B49. 1 indexed citations
16.
Belotte, J, et al.. (2012). Platinum-Based Combination Chemotherapy for the Treatment of Advanced-Stage Squamous Cell Carcinoma of the Vulva. Obstetrics and Gynecology. 120(Part 2). 458–460. 7 indexed citations
17.
Fletcher, Nicole M., Zhongliang Jiang, Rouba Ali‐Fehmi, et al.. (2012). Myeloperoxidase and free iron levels: Potential biomarkers for early detection and prognosis of ovarian cancer. Cancer Biomarkers. 10(6). 267–275. 33 indexed citations
18.
Belotte, J, et al.. (2011). Small bowel obstruction subsequent to Essure microinsert sterilization: a case report. Fertility and Sterility. 96(1). e4–e6. 17 indexed citations
19.
Belotte, J, et al.. (1996). [CURRENT ASPECTS OF CANCER CHEMOTHERAPY].. PubMed. 24. 165–75.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Salah T. Fayed Breakdown of academic impact, for papers by Doo Byung Chay Breakdown of academic impact, for papers by Lyndsay Willmott Breakdown of academic impact, for papers by Yuko Shiroyama Breakdown of academic impact, for papers by Shunji Kamazawa Breakdown of academic impact, for papers by Xiaohua Wu Breakdown of academic impact, for papers by Marsha Jones Breakdown of academic impact, for papers by Gabriel Lindahl Breakdown of academic impact, for papers by Shruthi Sriramkumar Breakdown of academic impact, for papers by Alberto Serrano‐Olvera
Rankless by CCL
2026